This inventor holds 41 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Formulation. Top assignees: Euro-Celtique S.a., Syngergistics. Active years: 1980-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Aberdeen, GB (1980 - 1987)
- Cambridge, GB (1988 - 2013)
Company Filing History:
Years Active: 1980-2013
Areas of Expertise:
Title: The Innovative Journey of Stewart Thomas Leslie: Pioneering Pharmaceutical Formulations
Introduction:
Stewart Thomas Leslie, a renowned inventor hailing from Cambridge, GB, has left an indelible mark in the field of pharmaceutical formulations. With an impressive portfolio of 41 patents, Leslie's contributions have revolutionized controlled release dosage forms, setting new standards in the industry.
Latest Patents:
Among Leslie's latest patents is a groundbreaking pharmaceutical formulation featuring a solid, oral controlled release dosage form. This innovation involves a matrix where a water-soluble active ingredient is dispersed, releasing the active component over a specific timeframe. The formulation ensures a median tmax of 2.5 to 6 hours, with a unique ratio of mean Cmax to mean plasma levels at 24 hours, ranging from 1.5 to 3.5. Additionally, Leslie's controlled release tramadol formulation has garnered significant attention for its efficacy in oral administration, utilizing tramadol as the primary active ingredient.
Career Highlights:
Throughout his illustrious career, Leslie has made significant strides in the pharmaceutical industry. Having worked with esteemed companies such as Euro-Celtique S.A. and Syngergistics, Leslie's expertise has been pivotal in developing cutting-edge solutions that address critical healthcare needs. His relentless pursuit of innovation has earned him a reputation as a trailblazer in the field of pharmaceutical formulations.
Collaborations:
Leslie's collaborative spirit has been instrumental in his success, working alongside accomplished professionals such as Ronald Brown Miller and Sandra Therese Malkowska. By fostering partnerships with like-minded visionaries, Leslie has been able to drive innovation and push the boundaries of pharmaceutical development further.
Conclusion:
In conclusion, Stewart Thomas Leslie stands as a visionary inventor whose exceptional contributions have reshaped the landscape of pharmaceutical formulations. With a wealth of patents to his name and a legacy of innovation, Leslie continues to inspire future generations of inventors to push the boundaries of what is possible in the realm of controlled release dosage forms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile